Advertisement
Cleveland Clinic announces readiness to enroll first patient in trial
Findings suggest an edge for fingolimod over dimethyl fumarate
Q&A on first major trials assessing laminectomy with/without fusion
Extra caution in order for this vulnerable population
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Phase 3 study of aducanumab enrolling in Las Vegas, Ohio, Florida
Cleveland Clinic receives OK for first-in-human trial
A quest to reduce inflammation, offer neuroprotection and enhance repair
Research seeks MRI biomarkers of in vivo pathogenesis
An intact rib cage bolsters clinical relevance
A Glimpse into the Future of Spine Surgery
Advertisement
Advertisement